Navigation Links
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
Date:12/18/2007

a single high dose of ABthrax

survived (p=0.0007 vs. placebo).

-- 50 percent of those that received a low dose survived (p=0.0064 vs.

placebo).

-- None of the monkeys in the placebo control group survived.

A separate study that measured 14-day survival in rabbits also demonstrated a statistically significant survival benefit versus placebo. All ABthrax-treated animals that survived in both studies were rapidly cleared of anthrax toxin and bacteria following intravenous administration of a single dose of ABthrax. In contrast, all placebo-treated animals remained bacteremic or toxemic and died.

HGS also reported today that it has completed the second safety study of ABthrax in human volunteers, bringing the total number of people who have participated in human safety trials to more than 180. The clinical results to date suggest that ABthrax was generally safe and well tolerated. In addition, the new study demonstrated that co-administration of ABthrax with the antibiotic Cipro (ciprofloxacin) did not affect the pharmacokinetics of either Cipro or ABthrax, and suggested that ABthrax can be administered in combination with antibiotics. This is a key finding given the important role that antibiotics are expected to continue to play in the treatment of anthrax disease.

The Need for New Means to Fight Anthrax Infections

Two options are currently available for the prevention or treatment of anthrax infections -- a vaccine and antibiotics. Both are essential to dealing with anthrax, but both have limitations. The anthrax vaccine takes several weeks following the initial doses before immunity is detectable, and requires multiple injections over a period of eighteen months, in addition to annual booster vaccination, to maintain protective immunity. Antibiotics are effective in killing anthrax bacteria, but are not effective against the anthrax toxins once those toxins have been released into the blood. Antibiotics also
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Demonstrates Mindful Approach to Aging
2. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
3. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
4. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
7. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
8. Promising Results in Treating Facial Bruising From Injectables
9. Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...Internet Week of Action ,, SILVER SPRING, Md.,...and Drug Administration today completed a coordina...ternational Internet Week of Action (IIWA), intend...cts. ,, (Logo: http://www.newscom.com/cgi-bin/...he FDA,s Office of Criminal Investigations (OCI), ...
(Date:11/19/2009)... Breast-Specific Gamma Imaging/Mol...ed and endorsed by two highly esteemed organizatio...y of Breast Imaging (SBI) and the American College...pporting the further application of this breakthro...breast cancer. ,, "These endorsements reinforce...
(Date:11/19/2009)... Internet Week of Action ,, SILVER SPRING, Md....and Drug Administration today completed a coordina...ternational Internet Week of Action (IIWA), intend...cts. ,, (Logo: http://www.newscom.com/cgi-bin... the FDA,s Office of Criminal Investigations (OCI)...
Breaking Medicine Technology:UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3FDA Issues 22 Warning Letters to Web Site Operators 2New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 1New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 2Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 1Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 2Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 3Photos 3A Breaking The No White After Labor Day Fashion Myth 55710 1Photos 3A Breaking The No White After Labor Day Fashion Myth 55710 2
...Incorporated,(Nasdaq: SPEX ) reported that patien...s potential type 2 diabetes drug, Naturlose(R), ha...ovide more than 300 patients spread,across 35 site...ent efforts,are underway in India, we believe that...s reported during the May 2008 Annual Shareholders...
...v. 6 Portola,Pharmaceuticals, a biopharmaceutical...significant advances in cardiovascular and inflamm...ata relevant to betrixaban, the,company,s novel or...P,receptor antagonist, will be presented at the Am... 2008. The conference will be held at the Ernest,N...
Other Medicine Technology:Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008 2
(Date:11/20/2009).... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutic...f Shareholders will be held on Monday, December 21...approval of two special resolutions. The first spe...le of all or substantially all of the assets of NU...the asset purchase agreement dated November 10, 20...
(Date:11/20/2009)... 20 Following a recall by Unilever...rom sale Shedd,s Country Crock ® Side Dishes ...rock ® Side Dishes DELUXE Four Cheese Pasta d...ollowing code dates and UPCs are affected: ,, ...eddar Broccoli Rice 21 oz, UPC 027400218316, Best ...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The American Dental Assoc...ministration (FDA) to establish appropriate classi...ting concern about the safety of whitening product...of professional consultation or examination by a d...of chemically based tooth whitening or bleaching a...
(Date:11/20/2009)..., Nov. 20 Samuel Gladdi...ne what it means to be "happy" during the holidays...ialty in family counseling and chair of the Depart...ding says research shows that it is the pressure t...pression during the holidays. ,, That,s why he,...
(Date:11/20/2009)...e November 20 in the Journal of the National Canc...hopes that often appear in news coverage of cancer...h the media and journals to help alleviate the pro... Woloshin, M.D., M.S., of Center for Medicine and ...licy and Clinical Practice in New Hampshire, and B...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...8 Mylan Inc. (Nasdaq: MYL ) today announced the...esloratadine Tablets, 5 mg, the generic version of.... This litigation has been pending in the U.S. Dis...he U.S. on July 1, 2012, or earlier in certain cir...
...ns and Logicalis Initiate Collaborative Sales Agre...tivity Implementations and Access to Federal Healt...pressus, a leader in interoperability of disparate...tions. These collaborative sales development and i...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD)...n interview and corporate presentation made by Cha... Small-Cap Investor Conference and Health Tech Inv... , , Aethlon Medical,s full company presentation ...
... "Western,s new Octi-Flo2™ is an ... care for eight patients at once," stated Jul...rises. , Westlake, OH (PR...lp Medical Response Teams to care for multiple pat...
... In New York City- Athlete and Lymelife,s wr...isease. Lyme Disease advocate and athlete, Perry ...se. Wanting to celebrate the movie and to decide f...s personal real life inspiration for the movie. ,...
... Although the median price of the average Ne...e January, 2009 (1 April, 09 Bloomberg Report); th... NZ dollar decline of between 16 and 28 percent ag... Island. , Christchurch, ...
Other Medicine News:Health News:Mylan Announces Clarinex(R) Settlement Agreement 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 3Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 4Health News:Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online 2Health News:Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online 3Health News:Octi-Flo2™ - 8 Patient Portable Oxygen Delivery System 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 3Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 4Health News:New Zealand Beach Front Property Offers Global Currency Rate Bargains 2
...th the Tupos LV/A+, the single-lead principle has ...for the first time. The complete system, which con... A+ lead, minimizes the scope of surgery and the r...m the atrium and the ventricle via a single lead. ...
...e Medtronic InSync II Marquis incorporates the lat...chronization benefits include separately programma... unique patient needs. Also included are new atria... heart failure patients who also experience atrial...
MRI-compatible brain biopsy needles.
RapidLoc Meniscal Repair System
Medicine Products: